Jacques Rachelle Suzanne
- SEC CIK
- 0001772610
In the past year, 1 open-market sale filing worth $53.9K and no purchases.
Current role at each company
- QURE uniQure N.V.Directoras of Jun 12, 2026
- CRBP Corbus Pharmaceuticals Holdings, Inc.Directoras of May 21, 2026
- AKTX Akari Therapeutics PlcChief Executive Officeras of Apr 30, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $53.9K
- 1 filing
- Net
- −$53.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jacques Rachelle Suzanne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QURE uniQure N.V.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Jacques Rachelle SuzanneDirector | SSale | −1.99K | $27.06 | −$53.9K | −5.6%33.9K after | |
| Jun 24, 2025 (view filing) | Jun 20 | 4 days | Jacques Rachelle SuzanneDirector | SSale | −2.11K | $14.45 | −$30.5K | −6.9%28.3K after | |
| Jun 17, 2024 (view filing) | Jun 13 | 4 days | Jacques Rachelle SuzanneDirector | SSale | −2.22K | $5.14 | −$11.4K | −13.4%14.4K after | |
| Jun 20, 2023 (view filing) | Jun 16 | 4 days | Jacques Rachelle SuzanneDirector | SSale | −2.30K | $18.76 | −$43.2K | −12.2%16.6K after | |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Jacques Rachelle SuzanneDirector | SSale | −384 | $20.02 | −$7.69K | −3.6%10.2K after |